Listed

Oragenics Inc

OGENNYSECIK 1174940HealthcareFiscal year ends Dec 31

Reports and events: 420 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Oragenics Inc, Reports and events
FiledFormWhat it isAccession number
2023-04-1717:29 ET10-KAnnual reportPeriod 2022-12-310001493152-23-012617
2023-04-1416:08 ET10-Q/AQuarterly report, amendedPeriod 2022-09-300001493152-23-012294
2023-04-1416:07 ET10-Q/AQuarterly report, amendedPeriod 2022-06-300001493152-23-012292
2023-04-1415:46 ET10-Q/AQuarterly report, amendedPeriod 2022-03-310001493152-23-012275
2023-04-1016:44 ET8-K4.02 Non-reliance on financial statements; 9.01 Financial statements and exhibits0001493152-23-011744
2023-04-0308:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-23-010530
2023-03-1408:57 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-007543
2023-03-0809:22 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-23-006979
2023-03-0108:35 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001493152-23-006354
2023-02-2416:22 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-006001
2023-02-0308:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-23-003472
2023-01-2316:05 ET8-K3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits0001493152-23-002194
2022-12-2316:19 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-036479
2022-12-2209:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-036215
2022-12-2016:55 ET8-K3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-036020
2022-12-1916:51 ET8-K1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-035889
2022-12-1616:05 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-22-035730
2022-11-1616:15 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-032629
2022-11-1416:34 ET10-QQuarterly reportPeriod 2022-09-300001493152-22-032121
2022-10-3116:00 ETDEF 14AProxy statementPeriod 2022-10-310001493152-22-029974
2022-10-0309:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-027359
2022-09-3009:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-027205
2022-08-2408:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-023899
2022-08-0916:06 ET10-QQuarterly reportPeriod 2022-06-300001493152-22-021757
2022-08-0316:05 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-021156
2022-07-2916:01 ET10-K/AAnnual report, amendedPeriod 2021-12-310001493152-22-020698
2022-07-0816:04 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-018889
2022-06-2317:22 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001493152-22-017614
2022-05-1709:30 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-014115
2022-05-1316:33 ET10-QQuarterly reportPeriod 2022-03-310001493152-22-013349
2022-04-1917:14 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-22-010461
2022-04-0607:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-009214
2022-03-2416:08 ET10-KAnnual reportPeriod 2021-12-310001493152-22-007664
2022-03-1007:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-006453
2022-02-2816:28 ET8-K3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001493152-22-005606
2022-01-2609:04 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-22-002245
2021-12-2008:19 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-031986
2021-12-2018:26 ET8-K5.02 Departure or appointment of officers or directors0001493152-21-031929
2021-12-1416:05 ET8-K7.01 Regulation FD disclosure0001493152-21-031403
2021-12-0109:02 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-030152
2021-11-2309:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-029651
2021-11-1516:06 ET10-QQuarterly reportPeriod 2021-09-300001493152-21-028580
2021-11-1219:29 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001493152-21-027910
2021-10-1316:05 ETDEF 14AProxy statementPeriod 2021-10-130001493152-21-025310
2021-10-0407:59 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-024430
2021-09-2416:23 ET8-K1.02 Termination of a material agreement0001493152-21-023597
2021-09-1509:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-022767
2021-09-0316:05 ET8-K5.08 Item not in the standard list0001493152-21-022010
2021-08-3007:42 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-021511
2021-08-2407:44 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001493152-21-021077

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:40 ET. Listed shows no prices and gives no investment advice.